All In Biotech

Drug Trial Radar · NCT07012746

A Clinical Trial of the Safety and Efficacy of TJ0113 Capsules in the Treatment of Patients With Age-related Hearing Loss

A Randomized, Double-Blind, Placebo-Parallel-Controlled Clinical Trial to Explore the Safety and Efficacy of TJ0113 Capsules in the Treatment of Patients With Age-related Hearing Loss

Last checked: Nov 19, 2026Latest source record: Jun 10, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

60

Planned (sponsor's estimate)

Start

Jun 7, 2025

Primary completion

Dec 2026

Study completion Apr 2027

Sponsor

Lead sponsor
Yilai ShuAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Hangzhou PhecdaMed Co., Ltd.
First posted
Jun 10, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 65 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to explore the safety and efficacy of TJ0113 capsules in patients with age-related hearing loss.

Conditions

  • Age Related Hearing Loss
  • Deafness

Interventions

  • TJ0113 capsulesDrug

    Oral intake on an empty stomach in the morning, 200 mg each time, fasting within half an hour after taking. It is recommended to keep the drug at the same time (± 1 h ) of a day .

  • Placebo capsulesDrug

    Oral intake on an empty stomach in the morning, 200 mg each time, fasting within half an hour after taking. It is recommended to keep the drug at the same time (± 1 h ) of a day .

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety of TJ0113 capsule in the treatment of patients with age-related hearing lossTime frame: Baseline, weeks 1, 4, 12, 24, and 1 week after discontinuation

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Eye & ENT Hospital of Fudan University

    Shanghai, Shanghai Municipality, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.